What is mitochondrial decline?
Mitochondrial decline is the age-related loss of mitochondrial function, including reduced NAD+ availability, lower oxidative capacity, and altered epigenetic regulation in tissues such as skeletal muscle. This page summ
What is mitochondrial decline?
Mitochondrial decline is the progressive, age-associated deterioration of mitochondrial function, encompassing reduced oxidative phosphorylation, diminished NAD+ availability, increased oxidative stress, and impaired organelle turnover. It is recognised as a key hallmark of ageing, alongside epigenetic alterations, and is studied in tissues including skeletal muscle [1]. The term is used interchangeably with age-related mitochondrial dysfunction; it is not a single molecular entity and therefore has no sequence, formula, or molecular weight. In the research literature, mitochondrial decline is a process-level descriptor rather than a discrete compound.
The work in this area centres on the NAD+-dependent sirtuin and PARP enzyme families, which link cellular energy status to epigenetic regulation and DNA repair, and on the mitochondrial electron transport chain as the downstream effector of oxidative capacity [1][2].
Research Studies
Nicotinamide riboside and epigenetic age acceleration in human skeletal muscle
Nicotinamide riboside (NR) is a vitamin B3 precursor to NAD+. In a study assessing the impact of 5-month NR supplementation and 4–6 weeks of high-intensity interval training (HIIT) on epigenetic age acceleration (EAA) in human skeletal muscle across three independent studies, NR supplementation was associated with a change in EAA as measured by seven epigenetic clocks [1]. The authors noted that mitochondrial dysfunction and epigenetic alterations are recognised hallmarks of ageing, and that both NR and HIIT have been proposed to ameliorate ageing-related mitochondrial decline, but their effects on skeletal muscle epigenetic ageing were not fully elucidated prior to this work [1]. The study population was human adults; the findings are specific to skeletal muscle and to the supplementation and training durations used.
Nicotinamide riboside and high-intensity interval training in human skeletal muscle
The same three-study analysis compared 5-month NR supplementation with 4–6 weeks of HIIT in human skeletal muscle [1]. The two interventions were described as divergent in their effects on epigenetic ageing, indicating that the mechanisms by which they act on mitochondrial and epigenetic endpoints are not equivalent [1]. This distinction is relevant when interpreting mitochondrial decline research: interventions that raise NAD+ availability and interventions that impose exercise stress do not necessarily converge on the same epigenetic clocks.
NAD+ precursors and cellular energy metabolism in adults aged 35 and over
A registered clinical study is exploring whether a daily food supplement, taken for one month, can improve markers of cellular health in adults aged 35 and over [2]. The supplement, Thrive+, contains ingredients that may support energy metabolism and antioxidant defences, including compounds that boost NAD+ levels [2]. The study background states that as people age, cells gradually lose their ability to produce energy efficiently and repair damage, a process linked to lower levels of NAD+, and that reduced antioxidant capacity and mitochondrial decline also contribute to ageing [2]. This is a study record; no outcome data are reported in the evidence provided.
NAD+ decline and mitochondrial function in ageing cells
NAD+ is described as essential for energy production and for maintaining healthy cell function, and its levels are reported to fall with age [2]. Mitochondrial decline is listed alongside reduced antioxidant capacity as a contributor to cellular ageing [2]. The relationship is presented as correlative in the study background; the evidence does not establish that raising NAD+ reverses mitochondrial decline in humans.
Epigenetic clocks and mitochondrial decline in human skeletal muscle
Epigenetic age acceleration was measured using seven epigenetic clocks in human skeletal muscle [1]. This approach allows mitochondrial and epigenetic endpoints to be assessed in the same tissue, which is relevant because mitochondrial dysfunction and epigenetic alterations are both recognised hallmarks of ageing [1]. The evidence does not specify which individual clocks responded, nor the magnitude of the change.
Exercise training and mitochondrial decline in human skeletal muscle
HIIT was administered for 4–6 weeks in the studies analysed [1]. The authors framed HIIT as an intervention proposed to ameliorate ageing-related mitochondrial decline, but reported that its effects on skeletal muscle epigenetic ageing diverged from those of NR [1]. The evidence does not provide a direct measure of mitochondrial function such as respiratory capacity or mitochondrial DNA copy number.
Comparison of NR and HIIT effects on epigenetic ageing
| Intervention | Duration | Tissue | Endpoint | Reported direction |
|---|---|---|---|---|
| Nicotinamide riboside (NR) | 5 months | Human skeletal muscle | Epigenetic age acceleration (7 clocks) | Associated with change in EAA [1] |
| High-intensity interval training (HIIT) | 4–6 weeks | Human skeletal muscle | Epigenetic age acceleration (7 clocks) | Divergent from NR [1] |
The table summarises the two interventions compared in the three independent studies [1]. No effect sizes are given in the evidence provided.
NAD+-boosting supplements and markers of cellular health
The registered study of Thrive+ is designed to assess markers of cellular health over one month in adults aged 35 and over [2]. The supplement is described as containing ingredients that may support energy metabolism and antioxidant defences, including compounds that boost NAD+ levels [2]. The record does not report whether mitochondrial decline markers are among the outcomes measured, nor any results.
Model limitations in mitochondrial decline research
The evidence provided covers human skeletal muscle studies and a registered human clinical study [1][2]. No animal-only or in vitro data are described in these sources. Where the literature more broadly relies on cell-culture or rodent models, those findings should be treated as model-specific and not assumed to translate to human physiology. The evidence here does not support claims about mitochondrial decline in tissues other than skeletal muscle, nor about clinical outcomes.
If you are reading this for personal health reasons
The materials described on this page are sold for laboratory research use only. We do not provide dosing information or medical guidance, and nothing here should be taken as a recommendation for personal use. Anyone considering a compound for themselves should speak to a licensed clinician.
Sources
- [1] The Divergent Effects of Nicotinamide Riboside and High-Intensity Exercise Training on Skeletal Muscle Epigenetic Aging — europe_pmc, CC BY.
- [2] Food Supplement for Longevity — ClinicalTrials.gov, public domain.